Drug Type Small molecule drug |
Synonyms Fosfomycin calcium, Fosfomycin calcium hydrate (JP17), Fosmicin + [1] |
Target |
Mechanism Peptidoglycan inhibitors, Cell wall inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (10 Jun 1980), |
Regulation- |
Molecular FormulaC3H9CaO5P |
InChIKeyUXDJUAWQGYDNQO-JSTPYPERSA-N |
CAS Registry26469-67-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02187 | - | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Urinary Tract Infections | CN | 01 Jan 1984 | |
Infectious enteritis | JP | 13 May 1982 | |
Complicated skin and skin structure infection | JP | 10 Jun 1980 | |
Cystitis | JP | 10 Jun 1980 | |
Dacryocystitis | JP | 10 Jun 1980 | |
Hordeolum | JP | 10 Jun 1980 | |
Otitis Media | JP | 10 Jun 1980 | |
Pyelonephritis | JP | 10 Jun 1980 | |
Sinusitis | JP | 10 Jun 1980 |
Not Applicable | 300 | TMP/SMX (TMP/SMX) | vvucnxfpml(vhifdwwdxu) = ypfvlkolff twynuwqbdu (nanchufwhn, gyypihnnom - evqmylvcsh) View more | - | 05 Jun 2023 | ||
(Fosfomycin) | vvucnxfpml(vhifdwwdxu) = zqgibizcdn twynuwqbdu (nanchufwhn, pghsteyayn - yahcgfnwss) View more |